Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000640727 | SCV000762326 | benign | Granulomatous disease, chronic, X-linked | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835891 | SCV002087139 | likely benign | Chronic granulomatous disease | 2019-12-05 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003937931 | SCV004755967 | likely benign | CYBB-related disorder | 2023-10-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |